검색어 : 통합검색[Habermann Norbert]
-
1
-
Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL)
-
Shi, Qian;
Schmitz, Norbert;
Ou, Fang-Shu;
Dixon, Jesse G.;
Cunningham, David;
Pfreundschuh, Michael;
Seymour, John F.;
Jaeger, Ulrich;
Habermann, Thomas M.;
Haioun, Corinne;
Tilly, Hervé
;
Ghesquieres, Hervé
;
Merli, Francesco;
Ziepert, Marita;
Herbrecht, Raoul;
Flament, Jocelyne;
Fu, Tommy;
Coiffier, Bertrand;
Flowers, Christopher R.;
Qian Shi, Fang-Shu Ou, Jesse G. Dixon, and Thomas M. Habermann, Mayo Clinic, Rochester, MN;
Norbert Schmitz, University of Muenster, Muenster;
Michael Pfreundschuh, Universitä
t des Saarlandes, Homburg;
Marita Ziepert, University of Leipzig, Leipzig, Germany;
David Cunningham, The Royal Marsden Hospital, Surrey, United Kingdom;
John F. Seymour, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia;
Ulrich Jaeger, Medical University of Vienna, Vienna, Austria;
Corinne...;
Qian Shi, Fang-Shu Ou, Jesse G. Dixon, and Thomas M. Habermann, Mayo Clinic, Rochester, MN;
Norbert Schmitz, University of Muenster, Muenster;
Michael Pfreundschuh, Universitä
t des Saarlandes, Homburg;
Marita Ziepert, University of Leipzig, Leipzig, Germany;
David Cunningham, The Royal Marsden Hospital, Surrey, United Kingdom;
John F. Seymour, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia;
Ulrich Jaeger, Medical University of Vien;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.36,
2018,
pp.2593-2602)
-
2
-
Multinuclear Sandwich‐type Complexes of Deprotonated β‐Cyclodextrin and Copper(<small>II</small>) Ions
-
Fuchs, Ralf;
Habermann, Norbert;
Klü
fers, Peter;
;
(Angewandte Chemie. International edition in English,
v.32,
1993,
pp.852-854)
-
3
-
Sandwichartige Mehrkernkomplexe aus deprotoniertem β‐Cyclodextrin und Kupfer(II)‐Ionen
-
Fuchs, Ralf;
Habermann, Norbert;
Klü
fers, Peter;
;
(Angewandte Chemie,
v.105,
1993,
pp.895-897)
-
4
-
Polyol‐Metall‐Komplexe, II<sup>[1]</sup> Kupfer(II)‐Komplexe mit mehrfach deprotoniertem Ethylenglycol, Anhydro‐erythrit oder Methyl‐α‐D‐mannopyranosid als Liganden
-
Habermann, Norbert;
Jung, Gisela;
Klaassen, Markus;
Klü
fers, Peter;
;
(Chemische Berichte,
v.125,
1992,
pp.809-814)
-
5
-
Cellulose in Schweizers Reagens: ein stabiler, polymerer Metallkomplex hoher Kettensteifheit
-
Burchard, Walther;
Seger, Bernd;
Habermann, Norbert;
Klü
fers, Peter;
Wilhelm, Ulf;
;
(Angewandte Chemie,
v.106,
1994,
pp.936-939)
-
6
-
Cellulose in Schweizer's Reagent: A Stable, Polymeric Metal Complex with High Chain Stiffness
-
Burchard, Walther;
Habermann, Norbert;
Klü
fers, Peter;
Seger, Bernd;
Wilhelm, Ulf;
;
(Angewandte Chemie. International edition in English,
v.33,
1994,
pp.884-887)
-
7
-
<i>In Vitro</i> Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
-
Sommerfeld, Mark R.;
Mü
ller, Gü
nter;
Tschank, Georg;
Seipke, Gerhard;
Habermann, Paul;
Kurrle, Roland;
Tennagels, Norbert;
Research and Development TD Metabolism, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany;
Research and Development TD Metabolism, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany;
Research and Development TD Metabolism, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany;
Process Development Biotechnology, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany;
Process Development Biotechnology, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany;
Research and Development TD Metabolism, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany;
Research and Development TD Metabolism, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany;
(PloS one,
v.5,
2010,
pp.e9540)
-
8
-
The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
-
Sargent, Daniel J.;
Shi, Qian;
Flowers, Christopher R.;
Schmitz, Norbert;
Habermann, Thomas M.;
Flament, Jocelyne;
Fu, Tommy;
Coiffier, Bertrand;
Department of Health Sciences Research, Mayo Clinic , Rochester , Minnesota , USA;
Department of Health Sciences Research, Mayo Clinic , Rochester , Minnesota , USA;
Department of Bone Marrow and Stem Cell Transplantation, Winship Cancer Institute of Emory University , Atlanta , Georgia , USA;
Department of Internal Medicine A, Hematology, Oncology and Pneumonology, University Hospital Muenster , Muenster , Germany;
Department of Hematology, Mayo Clinic , Rochester , Minnesota , USA;
Celgene Corporation , Boudry , Switzerland;
Celgene Corporation , Summit , New Jersey , USA;
Department of Hematology, Centre Hospitalier Lyon‐
Sud , Pierre‐
Benite , France;
(The oncologist,
v.22,
2017,
pp.1415-1418)
-
9
-
Atf3 links loss of epithelial polarity to defects in cell differentiation and cytoarchitecture
-
Donohoe, Colin D.;
Csordá
s, Gá
bor;
Correia, Andreia;
Jindra, Marek;
Klein, Corinna;
Habermann, Bianca;
Uhlirova, Mirka;
Perrimon, Norbert;
;
(PLoS genetics,
v.14,
2018,
pp.e1007241)
-
10
-
Comparative Transcriptional Profiling of the Axolotl Limb Identifies a Tripartite Regeneration-Specific Gene Program
-
Knapp, Dunja;
Schulz, Herbert;
Rascon, Cynthia Alexander;
Volkmer, Michael;
Scholz, Juliane;
Nacu, Eugen;
Le, Mu;
Novozhilov, Sergey;
Tazaki, Akira;
Protze, Stephanie;
Jacob, Tina;
Hubner, Norbert;
Habermann, Bianca;
Tanaka, Elly M.;
Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany;
Max Delbrueck Center for Molecular Medicine, Berlin, Germany;
Technical University Dresden, DFG Research Center for Regenerative Therapies Dresden, Dresden, Germany;
Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany;
Technical University Dresden, DFG Research Center for Regenerative Therapies Dresden, Dresden, Germany;
Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany;
Technical University Dresden, DFG Research Center for Regenerative Therapies Dresden, Dresden, Germany;
Technical University Dresden, DFG Research Center for Regenerative Therapies Dresden, Dresden, Germany;
Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany;
Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany;
Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany;
Max Delbrueck Center for Molecular Me;
(PloS one,
v.8,
2013,
pp.e61352)